A case analysis of thyroid dysfunction induced by immunotherapy in a patient with lung cancer

Objective: To explore factors influencing the occurrence of hypothyroidism and how collaboration among physicians, pharmacists, and nurses can reduce related complications. Methods: A clinical pharmacist analyzed and summarized the chemotherapy regimen and treatment course of one lung cancer patient who developed thyroid dysfunction during immunotherapy. Results: The occurrence of thyroid dysfunction was associated with multiple factors, including the immunotherapy regimen, drug toxicity, treatment duration, and patient adherence. Through appropriate and precise pharmacotherapy, the patients hypothyroidism was brought under control. Conclusion: By carrying out pharmacotherapy monitoring, clinical pharmacists can provide rational medication recommendations, assist physicians in formulating an optimal pharmacotherapeutic plan, help patients manage immunotherapy-induced thyroid dysfunction, and improve quality of life.